Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.


Updates from The Motley Fool

Latest updates on Epizyme from Fool.com.


Stock Performance

View Interactive EPZM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Epizyme.
Current Price: $10.85
Prev Close: $10.90
Open: $10.90
Bid: $10.75
Ask: $10.80
Day's Range: $10.50 - $11.05
52wk Range: $7.02 - $18.29
Volume: 104,188
Avg Vol 307,798
Market Cap: $452M
P/E (ttm): -5.96
EPS (ttm): ($1.83)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Epizyme.
CAPS Rating 3 out of 5
 
38 Outperform
6 Underperform
CAPS All Stars
 
13 Outperform
2 Underperform

How do you think Epizyme will perform against the market?



You pick for Epizyme is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Epizyme.

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

  • Exchange: NASDAQ